Earningsreport

Q2/2024 6/30/2024 EPS -0.480 ZacksConsensus -0.630 ActVsEst 0.150 - Beat

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com